Document is current
Any future updates will be listed below
-
Authors
Stein, Alexander
Simnica, Donjete https://orcid.org/0000-0003-2286-1381
Schultheiß, Christoph https://orcid.org/0000-0001-9789-5776
Scholz, Rebekka https://orcid.org/0000-0003-2077-0718
Tintelnot, Joseph
Gökkurt, Eray
von Wenserski, Lisa
Willscher, Edith
Paschold, Lisa https://orcid.org/0000-0003-0020-1315
Sauer, Markus
Lorenzen, Sylvie
Riera-Knorrenschild, Jorge
Depenbusch, Reinhard
Ettrich, Thomas J
Dörfel, Steffen
Al-Batran, Salah-Eddin
Karthaus, Meinolf
Pelzer, Uwe
Waberer, Lisa
Hinke, Axel
Bauer, Marcus
Massa, Chiara
Seliger, Barbara https://orcid.org/0000-0002-5544-4958
Wickenhauser, Claudia
Bokemeyer, Carsten
Hegewisch-Becker, Susanna
Binder, Mascha https://orcid.org/0000-0003-0663-3004
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03174405 at ClinicalTrials.govDocuments that mention this clinical trial
PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer
https://doi.org/10.1136/jitc-2021-002844
-
Funding
Funding for this research was provided by:
AIO Studien gGmbH (AVETUX)
- License Information
